Use of inotropes and vasopressor agents in critically ill patients

Br J Pharmacol. 2012 Apr;165(7):2015-33. doi: 10.1111/j.1476-5381.2011.01588.x.

Abstract

Inotropes and vasopressors are biologically and clinically important compounds that originate from different pharmacological groups and act at some of the most fundamental receptor and signal transduction systems in the body. More than 20 such agents are in common clinical use, yet few reviews of their pharmacology exist outside of physiology and pharmacology textbooks. Despite widespread use in critically ill patients, understanding of the clinical effects of these drugs in pathological states is poor. The purpose of this article is to describe the pharmacology and clinical applications of inotropic and vasopressor agents in critically ill patients.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acute Kidney Injury / drug therapy
  • Animals
  • Cardiac Output / drug effects
  • Cardiac Output / physiology
  • Cardiotonic Agents / pharmacokinetics
  • Cardiotonic Agents / pharmacology
  • Cardiotonic Agents / therapeutic use*
  • Catecholamines / physiology
  • Critical Care / methods*
  • Critical Illness*
  • Heart Arrest / drug therapy
  • Hormones / physiology
  • Humans
  • Models, Cardiovascular
  • Myocardial Contraction / drug effects
  • Myocardial Contraction / physiology
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / physiology
  • Sepsis / drug therapy
  • Vasoconstrictor Agents / pharmacokinetics
  • Vasoconstrictor Agents / pharmacology
  • Vasoconstrictor Agents / therapeutic use*

Substances

  • Cardiotonic Agents
  • Catecholamines
  • Hormones
  • Vasoconstrictor Agents